Report: FDA and Biogen brought Alzheimer's drug to market despite internal concerns
Report: FDA and Biogen brought Alzheimer's drug to market despite internal concerns
The Food and Drug Administration's review process for an Alzheimer's treatment found that the agency "deviated" from its standard procedures to approve the Aduhelm drug.
from ABC News: Top Stories https://ift.tt/Rw2iufj
The Food and Drug Administration's review process for an Alzheimer's treatment found that the agency "deviated" from its standard procedures to approve the Aduhelm drug.
from ABC News: Top Stories https://ift.tt/Rw2iufj
Report: FDA and Biogen brought Alzheimer's drug to market despite internal concerns
![Report: FDA and Biogen brought Alzheimer's drug to market despite internal concerns]()
Reviewed by kd
on
4:20 PM
Rating:
No comments: